511 Therapeutics, Inc.

Biotechnology company · Cambridge, Massachusetts, United States

511 Therapeutics, Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2022. It has reported private securities offerings to the US SEC, most recently $49,999 sold in a notice filed in 2022.

Profile compiled from public records. Is this your company? Request a correction or update

511 Therapeutics at a glance

Typebiotechnology company

HeadquartersCambridge, Massachusetts, United States

Earliest incorporation on record2022

SEC CIK1946264

What does 511 Therapeutics do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $49,999 sold (2022).

Frequently asked questions about 511 Therapeutics

Where is 511 Therapeutics headquartered?

511 Therapeutics, Inc. is headquartered in Cambridge, Massachusetts, United States.

What does 511 Therapeutics do?

511 Therapeutics, Inc. is a biotechnology company.

When was 511 Therapeutics founded?

The earliest incorporation on record for 511 Therapeutics, Inc. is in 2022, according to public company registers.

Similar companies

Editas Medicine, Inc.Cambridge, Massachusetts, United States
Moderna, Inc.Cambridge, Massachusetts, United States
Relay Therapeutics, Inc.Cambridge, Massachusetts, United States
Beam Therapeutics Inc.Cambridge, Massachusetts, United States
Genzyme CorpCambridge, Massachusetts, United States
Neutrolis Inc.Cambridge, Massachusetts, United States
Biogen Inc.Cambridge, Massachusetts, United States
Black Diamond Therapeutics, Inc.Cambridge, Massachusetts, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences